PeptiDream Inc.

Tokyo Stock Exchange 4587.T

PeptiDream Inc. Market Capitalization on January 14, 2025: USD 1.77 B

PeptiDream Inc. Market Capitalization is USD 1.77 B on January 14, 2025, a 41.27% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

PeptiDream Inc. 52-week high Market Capitalization is USD 2.59 B on December 02, 2024, which is 46.14% above the current Market Capitalization.
PeptiDream Inc. 52-week low Market Capitalization is USD 1.07 B on February 14, 2024, which is -39.52% below the current Market Capitalization.
PeptiDream Inc. average Market Capitalization for the last 52 weeks is USD 1.86 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Tokyo Stock Exchange: 4587.T

PeptiDream Inc.

CEO	Dr. Patrick Crawford Reid Ph.D.
IPO Date	June 12, 2013
Location	Japan
Headquarters	3-25-23 Tonomachi
Employees	745
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.

Key trends

Past 5 years